ReNeuron Launches Phase I Clinical Trial

RenNeuron has been approved for a Phase I clinical trial for its manufactured stem cell line in stroke patients. Personally, I am wondering if this could also have implications for treatment of people with Cerebral Palsy. I have emailed the company this question, but have not received a response. Below is some information on the study and links for more information.

The study is designed to test the safety of a manufactured neural stem cell line (CTX cells) delivered by injection into the damaged brains of male patients 60 years of age or over who remain moderately to severely disabled 6-24 months following an ischemic stroke. In addition the trial will evaluate a range of potential efficacy measures for future trials. Treatment will involve a single injection of one of four doses of CTX cells into the patient's brain in a carefully controlled neurosurgical operation performed under general anesthetic. The trial is designed to treat 12 patients and measure outcomes over 24 months. Patients will be invited to participate in a long-term follow-up trial for a further 8 years.

More information on this study can be found at clinicaltrials.gov 

More information on ReNeuron can be found at www.reneuron.com